STOCK TITAN

[Form 4] Life360, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock. He received a grant of 4,840 Restricted Stock Units at no cost, bringing his directly held RSUs to 5,676, which vest quarterly from May 15, 2026, subject to continued service. Through the John Coghlan Living Trust, he sold a total of 4,000 shares in open-market transactions at weighted average prices of about $43.95 and $44.64, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. After these sales, that trust holds 28,431 shares, while a separate Grantor Retained Annuity Trust holds 55,494 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider COGHLAN JOHN PHILIP
Role null
Sold 4,000 shs ($176K)
Type Security Shares Price Value
Sale Common stock 3,796 $43.95 $167K
Sale Common stock 204 $44.64 $9K
Grant/Award Common stock 4,840 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common stock — 28,635 shares (Indirect, Held by the John Coghlan Living Trust); Common stock — 5,676 shares (Direct, null); Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)
Footnotes (1)
  1. Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date. Includes 5,676 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.53 to $44.52, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.64, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
Shares sold 4,000 shares Open-market sales by John Coghlan Living Trust
Sale price (larger block) $43.95 per share Weighted average price for 3,796 shares sold
Sale price (smaller block) $44.64 per share Weighted average price for 204 shares sold
RSU grant 4,840 RSUs New award of Restricted Stock Units to director
Direct RSU holdings 5,676 RSUs RSUs held after grant, each for one common share
Living Trust holdings 28,431 shares Shares held by John Coghlan Living Trust after sales
GRAT holdings 55,494 shares Shares held by 2025 Grantor Retained Annuity Trust
Restricted Stock Units ("RSUs") financial
"Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Grantor Retained Annuity Trust financial
"Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
weighted average price financial
"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
COGHLAN JOHN PHILIP

(Last)(First)(Middle)
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310

(Street)
SAN MATEO CALIFORNIA 94403

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock05/29/2026A(1)4,840A$05,676(2)D
Common stock06/01/2026S(3)3,796D$43.95(4)28,635IHeld by the John Coghlan Living Trust
Common stock06/01/2026S(3)204D$44.64(5)28,431IHeld by the John Coghlan Living Trust
Common Stock55,494IHeld by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date.
2. Includes 5,676 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $43.53 to $44.52, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
5. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.64, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
Remarks:
/s/ Jay Sood, as Attorney-in-Fact06/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)